TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma.

Andrew H Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.